PF3D7_1453600

PF3D7_1453600 (RAP-1) is a rhoptry-associated protein of P. falciparum that forms the core of a multi-component antigen complex and functions post-invasion to support intraerythrocytic parasite growth (PMID:2200961, PMID:2263413, PMID:28205319). It is synthesized as a precursor carrying a cleavable N-terminal signal peptide and is trafficked to the rhoptries through the secretory pathway, its maturation from the 86-kDa precursor (Pr86) to mature p82 being reversibly blocked by brefeldin A and low temperature and irreversibly blocked by N-ethylmaleimide (PMID:8719244). Following transport to forming rhoptries, Pr86 undergoes progressive N-terminal cleavage to p82 and then p67, and assembles into low-molecular-weight complexes with the RAP-2 product p39 and the RAP-3 product p37 (PMID:9574915, PMID:17553576). RAP-1 is required for targeting RAP-2 to the rhoptries (PMID:29307564), and after merozoite release it binds the surface of normal erythrocytes, a tagging activity lost in RAP-1-disruption mutants (PMID:17624849). Rather than being required for rhoptry morphology or erythrocyte invasion, the RAP complex acts post-invasion to maintain normal parasitophorous vacuolar membrane structure and support intraerythrocytic growth, with conditional knockdown producing altered PVM, delayed growth, and reduced parasitemia (PMID:28205319). Monoclonal antibodies against RAP-1, including those recognizing inhibitory epitopes near the p80→p65 cleavage site and near the N-terminus of p67, inhibit parasite growth and invasion in vitro (PMID:2200961, PMID:2263413, PMID:1279419, PMID:9423886).

1. 1990 High

   Establishing that RAP-1 is a rhoptry-associated multi-protein antigen whose components derive from a single precursor addressed whether these co-purifying proteins represent one functional entity and a candidate for growth-inhibitory immunity.

   Evidence Immunoaffinity purification, SDS-PAGE, sequencing, and monoclonal antibody growth-inhibition assay in P. falciparum

   PMID:2200961 PMID:2263413

   Open questions at the time

   • The precise molecular function of RAP-1 was not defined
   • The identity of the cleavage events generating the smaller components was not resolved
2. 1992 High

   Mapping inhibitory epitopes relative to the p80→p65 cleavage site tied antibody-mediated growth inhibition to a specific processing event and linked p65 generation to merozoite release rather than invasion.

   Evidence Epitope mapping with fusion proteins and synthetic peptides plus in vitro growth inhibition in P. falciparum

   PMID:1279419

   Open questions at the time

   • The protease responsible for the p80→p65 cleavage was not identified
   • The functional role of p65 was not established
3. 1995 High

   Defining the secretory-pathway dependence of RAP-1 maturation established how the protein reaches the rhoptries and revealed a signal peptide plus an unaccounted-for modification during maturation.

   Evidence Brefeldin A, low-temperature and NEM blocks, in vitro translation, and immunoprecipitation in P. falciparum

   PMID:8719244

   Open questions at the time

   • The nature of the modification distinguishing the ~84-kDa translation product from Pr86 was not identified
   • The trafficking receptors/machinery routing RAP-1 to rhoptries were not defined
4. 1998 High

   Ordering the sequential N-terminal cleavages (Pr86→p82→p67) and showing complex assembly precedes processing clarified the maturation sequence and demonstrated RAP-1 stays rhoptry-resident rather than relocalizing to the merozoite surface.

   Evidence Epitope-specific immunoblot, IFA, size fractionation with brefeldin A block, and purified merozoite analysis in P. falciparum

   PMID:9574915

   Open questions at the time

   • The proteases performing the sequential cleavages were not identified
   • The functional consequence of each cleavage step was not determined
5. 1998 Medium

   Identifying a second inhibitory epitope near the N-terminus of p67 reinforced p67 as an antibody-accessible, functionally relevant processing product implicated in invasion.

   Evidence Monoclonal antibody 1D6 generation, epitope mapping, and in vitro invasion inhibition in P. falciparum

   PMID:9423886

   Open questions at the time

   • Single-lab finding not independently confirmed
   • The molecular basis by which anti-p67 antibodies block invasion was not defined
6. 2007 Medium

   Demonstrating that RAP-1 is the core of two low-molecular-weight DRM complexes with RAP-2 and RAP-3 defined its biochemical partners and membrane association.

   Evidence Detergent-resistant membrane purification, BN-PAGE, and mass spectrometry in P. falciparum

   PMID:17553576

   Open questions at the time

   • No functional consequence was assigned directly to RAP-1 within these complexes
   • The stoichiometry and higher-order aggregation state were not resolved
7. 2007 High

   Genetic disruption combined with surface iodination showed RAP-1 is specifically required to tag normal erythrocytes after merozoite release, assigning it a discrete cell-surface binding activity.

   Evidence RAP-1 gene-disruption mutants, surface iodination, and erythrocyte binding assays in P. falciparum

   PMID:17624849

   Open questions at the time

   • The erythrocyte receptor bound by RAP-1 was not identified
   • The physiological purpose of erythrocyte tagging was not established
8. 2017 High

   Conditional knockdown redefined the RAP complex as dispensable for invasion but essential post-invasion for PVM integrity and intraerythrocytic growth, overturning an assumed invasion role.

   Evidence Conditional knockdown, electron microscopy, and in vitro/in vivo growth assays in P. falciparum and P. berghei ANKA

   PMID:28205319

   Open questions at the time

   • The molecular mechanism linking RAP-1 to PVM structure was not defined
   • Whether RAP-1 acts directly at the PVM or via its complex partners was not distinguished
9. 2018 Medium

   In P. berghei, knockout established RAP-1 as required for RAP-2 rhoptry targeting and as a contributor to virulence, connecting complex assembly to infection outcome.

   Evidence Comparative genomics, RAP1- and RAP2/3-deficient mutants, and mouse infection assays in P. berghei ANKA

   PMID:29307564

   Open questions at the time

   • Single-lab finding
   • The mechanism by which RAP-1 directs RAP-2 to rhoptries was not resolved
   • Whether the virulence phenotype reflects the PVM/growth role was not tested

• The direct molecular mechanism by which RAP-1 maintains PVM integrity and supports intraerythrocytic growth, and the identity of its erythrocyte-surface receptor, remain unresolved.
• No biochemical activity assigned to RAP-1 beyond complex assembly and erythrocyte binding
• No structural model of RAP-1 or its complexes
• The protease(s) generating p82/p67 remain unidentified